{"id":55181,"date":"2026-01-22T21:16:02","date_gmt":"2026-01-22T13:16:02","guid":{"rendered":"https:\/\/flcube.com\/?p=55181"},"modified":"2026-01-22T21:16:04","modified_gmt":"2026-01-22T13:16:04","slug":"matwings-technology-partners-with-leading-us-biotech-on-aiacclbio-platform-for-biopharmaceutical-pipeline","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=55181","title":{"rendered":"Matwings Technology Partners with Leading US Biotech on AIACCLBIO Platform for Biopharmaceutical Pipeline"},"content":{"rendered":"\n<p><strong>Matwings Technology<\/strong>, a pioneer in AI\u2011driven protein engineering, announced a strategic biopharmaceutical pipeline collaboration with a leading U.S. biotechnology company founded by top\u2011tier life sciences entrepreneurs. Under the agreement, Matwings will receive <strong>upfront development payments, development milestones, commercialization proceeds, and additional licensing revenue<\/strong> for its contributions to the joint pipeline.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-deal-structure-amp-financial-terms\">Deal Structure &amp; Financial Terms<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Partners<\/strong><\/td><td>Matwings Technology (AI platform) \/ Leading U.S. biotech (pipeline development)<\/td><\/tr><tr><td><strong>Deal Type<\/strong><\/td><td>Biopharmaceutical pipeline collaboration agreement<\/td><\/tr><tr><td><strong>Matwings\u2019 Role<\/strong><\/td><td>Provide AI\u2011driven protein design and optimization via AIACCLBIO platform<\/td><\/tr><tr><td><strong>Financial Terms<\/strong><\/td><td>Upfront development payment + milestones + revenue share + potential licensing fees<\/td><\/tr><tr><td><strong>Technology Access<\/strong><\/td><td>Exclusive application of AIACCLBIO for designated pipeline targets<\/td><\/tr><tr><td><strong>Significance<\/strong><\/td><td>Validates Matwings\u2019 AI platform in a high\u2011value international partnership<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-platform-aiacclbio\">Technology Platform: AIACCLBIO<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Platform:<\/strong> <strong>AIACCLBIO<\/strong> \u2013 industry\u2011leading AI protein design platform<\/li>\n\n\n\n<li><strong>Training Data:<\/strong> Pre\u2011trained on <strong>VenusPod<\/strong>, the world\u2019s largest protein sequence dataset<\/li>\n\n\n\n<li><strong>Core Functions:<\/strong><\/li>\n\n\n\n<li><strong>AI\u2011directed evolution<\/strong> for rapid protein optimization<\/li>\n\n\n\n<li><strong>Enzyme mining<\/strong> to identify novel functional candidates<\/li>\n\n\n\n<li><strong>De novo design<\/strong> for creating bespoke therapeutic proteins<\/li>\n\n\n\n<li><strong>Key Advantage:<\/strong> Focuses on <strong>extreme tolerance<\/strong> improvements, including resistance to high temperatures and strong acids\/bases, enabling robust manufacturing and novel delivery routes.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-implications-amp-market-context\">Strategic Implications &amp; Market Context<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>AI Drug Discovery Market:<\/strong> Global market valued at <strong>US$1.1\u202fbillion<\/strong> in 2024, projected to exceed <strong>US$4.5\u202fbillion<\/strong> by 2030 (CAGR\u202f\u2248\u202f30%).<\/li>\n\n\n\n<li><strong>Platform Validation:<\/strong> The partnership provides non\u2011dilutive funding and validates AIACCLBIO\u2019s capabilities on real\u2011world therapeutic targets.<\/li>\n\n\n\n<li><strong>Competitive Moat:<\/strong> Access to <strong>VenusPod<\/strong> and expertise in extreme\u2011tolerance engineering differentiate Matwings from other AI\u2011protein players.<\/li>\n\n\n\n<li><strong>Pipeline Focus:<\/strong> Collaboration likely targets <strong>industrial enzymes<\/strong> and <strong>biotherapeutics<\/strong> requiring stability under harsh processing conditions.<\/li>\n\n\n\n<li><strong>Next Steps:<\/strong> Matwings expects to expand AIACCLBIO applications to additional pharmaceutical and biotechnology partners in 2026.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief includes forward\u2011looking statements regarding development timelines, revenue expectations, and platform expansion for AIACCLBIO. Actual outcomes may vary due to technological risks, partnership performance, and market dynamics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Matwings Technology, a pioneer in AI\u2011driven protein engineering, announced a strategic biopharmaceutical pipeline collaboration with&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[99,2156],"class_list":["post-55181","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-ai","tag-matwings-technology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Matwings Technology Partners with Leading US Biotech on AIACCLBIO Platform for Biopharmaceutical Pipeline - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Matwings Technology, a pioneer in AI\u2011driven protein engineering, announced a strategic biopharmaceutical pipeline collaboration with a leading U.S. biotechnology company founded by top\u2011tier life sciences entrepreneurs. Under the agreement, Matwings will receive upfront development payments, development milestones, commercialization proceeds, and additional licensing revenue for its contributions to the joint pipeline.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=55181\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Matwings Technology Partners with Leading US Biotech on AIACCLBIO Platform for Biopharmaceutical Pipeline\" \/>\n<meta property=\"og:description\" content=\"Matwings Technology, a pioneer in AI\u2011driven protein engineering, announced a strategic biopharmaceutical pipeline collaboration with a leading U.S. biotechnology company founded by top\u2011tier life sciences entrepreneurs. Under the agreement, Matwings will receive upfront development payments, development milestones, commercialization proceeds, and additional licensing revenue for its contributions to the joint pipeline.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=55181\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-22T13:16:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-22T13:16:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55181#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55181\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Matwings Technology Partners with Leading US Biotech on AIACCLBIO Platform for Biopharmaceutical Pipeline\",\"datePublished\":\"2026-01-22T13:16:02+00:00\",\"dateModified\":\"2026-01-22T13:16:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55181\"},\"wordCount\":330,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"AI\",\"Matwings Technology\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55181#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55181\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=55181\",\"name\":\"Matwings Technology Partners with Leading US Biotech on AIACCLBIO Platform for Biopharmaceutical Pipeline - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-01-22T13:16:02+00:00\",\"dateModified\":\"2026-01-22T13:16:04+00:00\",\"description\":\"Matwings Technology, a pioneer in AI\u2011driven protein engineering, announced a strategic biopharmaceutical pipeline collaboration with a leading U.S. biotechnology company founded by top\u2011tier life sciences entrepreneurs. Under the agreement, Matwings will receive upfront development payments, development milestones, commercialization proceeds, and additional licensing revenue for its contributions to the joint pipeline.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55181#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55181\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55181#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Matwings Technology Partners with Leading US Biotech on AIACCLBIO Platform for Biopharmaceutical Pipeline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Matwings Technology Partners with Leading US Biotech on AIACCLBIO Platform for Biopharmaceutical Pipeline - Insight, China&#039;s Pharmaceutical Industry","description":"Matwings Technology, a pioneer in AI\u2011driven protein engineering, announced a strategic biopharmaceutical pipeline collaboration with a leading U.S. biotechnology company founded by top\u2011tier life sciences entrepreneurs. Under the agreement, Matwings will receive upfront development payments, development milestones, commercialization proceeds, and additional licensing revenue for its contributions to the joint pipeline.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=55181","og_locale":"en_US","og_type":"article","og_title":"Matwings Technology Partners with Leading US Biotech on AIACCLBIO Platform for Biopharmaceutical Pipeline","og_description":"Matwings Technology, a pioneer in AI\u2011driven protein engineering, announced a strategic biopharmaceutical pipeline collaboration with a leading U.S. biotechnology company founded by top\u2011tier life sciences entrepreneurs. Under the agreement, Matwings will receive upfront development payments, development milestones, commercialization proceeds, and additional licensing revenue for its contributions to the joint pipeline.","og_url":"https:\/\/flcube.com\/?p=55181","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-22T13:16:02+00:00","article_modified_time":"2026-01-22T13:16:04+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=55181#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=55181"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Matwings Technology Partners with Leading US Biotech on AIACCLBIO Platform for Biopharmaceutical Pipeline","datePublished":"2026-01-22T13:16:02+00:00","dateModified":"2026-01-22T13:16:04+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=55181"},"wordCount":330,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["AI","Matwings Technology"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=55181#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=55181","url":"https:\/\/flcube.com\/?p=55181","name":"Matwings Technology Partners with Leading US Biotech on AIACCLBIO Platform for Biopharmaceutical Pipeline - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-01-22T13:16:02+00:00","dateModified":"2026-01-22T13:16:04+00:00","description":"Matwings Technology, a pioneer in AI\u2011driven protein engineering, announced a strategic biopharmaceutical pipeline collaboration with a leading U.S. biotechnology company founded by top\u2011tier life sciences entrepreneurs. Under the agreement, Matwings will receive upfront development payments, development milestones, commercialization proceeds, and additional licensing revenue for its contributions to the joint pipeline.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=55181#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=55181"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=55181#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Matwings Technology Partners with Leading US Biotech on AIACCLBIO Platform for Biopharmaceutical Pipeline"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55181","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=55181"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55181\/revisions"}],"predecessor-version":[{"id":55182,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55181\/revisions\/55182"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=55181"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=55181"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=55181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}